Alivus Life Sciences (NSE:ALIVUS) FFO


NSE:ALIVUS Alivus Life Sciences Ltd NSE:ALIVUS
83 GF Score
Price ₹1,108.30
GF Value ₹1,012.74
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Alivus Life Sciences FFO?

FFO (Funds from operations) only applies to REITs.

NSE:ALIVUS
83GF Score
Alivus Life Sciences Ltd NSE:ALIVUS
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Alivus Life Sciences (NSE:ALIVUS) Overvalued in 2026?

Based on GuruFocus' analysis, Alivus Life Sciences stock appears to be overvalued. The current stock price of ₹1,108.30 is trading 9.4% above its estimated GF Value™ of ₹1,012.74. GuruFocus considers Alivus Life Sciences to be Fairly Valued.

Key valuation signals for NSE:ALIVUS:

  • FFO:
  • GF Value™: ₹1,012.74 vs. price of ₹1,108.30 (9.4% above fair value)
  • GF Score™: 83/100 with 4 warning signs

No single metric tells the full story. See the NSE:ALIVUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Alivus Life Sciences Business Description

Other Exchanges 543322:India
Address 470, Cardinal Gracious Road, 4th Floor, OIA House, Andheri (East), Mumbai, MH, IND, 400 099
Alivus Life Sciences Ltd develops, manufactures, and supplies high-quality active pharmaceutical ingredients for cardiovascular disease, central nervous system disorders, pain management, diabetes, urology, gastrointestinal disorders, and other therapeutic areas.
83GF Score

Get the complete analysis for NSE:ALIVUS

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,108.30
Price
₹1,012.74
GF Value